Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$196K 7326
2022
Q1
$196K Buy
+10,000
New +$175K ﹤0.01% 5832
2021
Q3
Sell
-200,000
Closed -$3.06M 7094
2021
Q2
$3.06M Buy
+200,000
New +$3.11M ﹤0.01% 3407
2016
Q4
Sell
-207,400
Closed -$7.62M 3594
2016
Q3
$7.62M Buy
+207,400
New +$6.97M 0.01% 1078
2015
Q4
Sell
-50,000
Closed -$1.88M 3666
2015
Q3
$1.88M Sell
50,000
-10,000
-17% -$409K ﹤0.01% 1946
2015
Q2
$2.9M Buy
+60,000
New +$3.08M 0.01% 1702
2015
Q1
Sell
-260,400
Closed -$17.1M 3934
2014
Q4
$17.1M Buy
260,400
+60,100
+30% +$4.19M 0.04% 689
2014
Q3
$15.2M Sell
200,300
-88,900
-31% -$7.35M 0.04% 632
2014
Q2
$23.8M Buy
+289,200
New +$21.5M 0.07% 399
2014
Q1
Sell
-285,457
Closed -$20.5M 3752
2013
Q4
$20.5M Buy
285,457
+26,284
+10% +$1.91M 0.06% 342
2013
Q3
$18.3M Buy
259,173
+14,971
+6% +$1M 0.06% 389
2013
Q2
$15.2M Buy
+244,202
New +$15.1M 0.05% 427

Other funds holding NOV

Israel Englander's NOV Position: Q2 2026 in Review

Israel Englander reduced its NOV (NOV) stake by 10% in Q2 2026, selling an estimated $5.92M and leaving 2,589,188 shares worth $48M. The position accounts for 0.02% of the portfolio, ranked #922.

Israel Englander first reported a position in NOV in Q3 2013 and has held it in 43 quarters since. The position peaked at $103M in Q1 2024. 485 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Israel Englander held 2,589,188 shares of NOV worth $48M as of Q2 2026.
  • Israel Englander sold 297,222 NOV shares in Q2 2026, an estimated $5.92M.
  • NOV made up 0.02% of Israel Englander's portfolio in Q2 2026, its #922 holding.
  • Israel Englander first reported a position in NOV in Q3 2013 and has held it in 43 quarters since.
  • Israel Englander's NOV position peaked at $103M in Q1 2024.
  • 485 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.